Healthcare & Medical Devices Global On demand · 24-48h

Global Intracranial Pressure Monitor Market Strategic Research Report

Global Intracranial Pressure Monitor Market Strategic Resear…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Intracranial Pressure Monitor Market
$5952025
5.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Invasive, Non-invasive

By Application: Hospital, Clinic, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Integra LifeSciences, Medtronic, Johnson & Johnson, Sophysa, Raumedic, Spiegelberg, HaiWeiKang, HeadSense Medical, Vittamed, Comen, PrimaNova, TALEND MEDICAL

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 109 pages
Market size 2025
$595
Million USD
Forecast CAGR
5.7%
2025-2032
Forecast 2032
$877.1
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Intracranial Pressure Monitor market size is predicted to grow from US$ 595 million in 2025 to US$ 883 million in 2032; it is expected to grow at a CAGR of 5.7% from 2026 to 2032.

An intracranial pressure (ICP) monitor is a medical device system designed for short-term monitoring and recording of intracranial pressures and pressure trends. It typically includes a pressure sensor/transducer, a bedside monitor with display and alarms, interconnecting hardware, and related single-use components. When used with EVD setups or parenchymal/other intracranial probes, it provides continuous pressure waveforms and actionable trend changes to evaluate intracranial compliance and the risk of intracranial hypertension, supporting time-sensitive decisions in neurocritical care, perioperative neurosurgery, and emergency settings.In 2025, global Intracranial Pressure Monitor production reached approximately 55.32 K Units and price is about 11 K USD/Unit.The average gross profit margin of this product is 48%.

Strengthening neurocritical care and trauma systems is moving ICP monitoring toward more repeatable and auditable workflow-based management. Across severe brain injury, aneurysmal subarachnoid hemorrhage, hemorrhagic/ischemic edema, hydrocephalus, and post-operative surveillance, demand is increasingly driven by continuous trends and waveform fidelity rather than occasional spot checks. Clinicians also favor “monitor-plus-intervention” pathways: EVD-based setups can provide pressure information while enabling therapeutic drainage, supporting higher utilization stickiness and more standardized use in core departments.

Invasive monitoring carries risks such as infection, bleeding, obstruction, calibration constraints, and signal drift, meaning device value depends not only on measurement accuracy but also on insertion workflows, sterile consumable systems, nursing adherence, and practical troubleshooting. Variability in staff training and protocol execution can materially affect real-world adoption and reputation. Moreover, ongoing clinical debate around “when to use,” “how to use,” and the relationship to outcome improvements shifts purchasing attention toward evidence alignment, guideline consistency, and lifecycle cost predictability.Downstream needs are evolving from “numbers” to trend-driven management. ICUs increasingly require stable continuous streams, clearer waveforms, and event annotation so ICP data can be operationally linked with sedation/analgesia strategies, osmotherapy, drainage protocols, and imaging follow-up. Neurosurgery and emergency teams prioritize rapid access, perioperative convenience, and complication prevention toolchains. In parallel, hospital digitalization is accelerating interoperability with bedside monitors, electronic records, and data platforms—raising expectations for traceable consumables, easier training, remote quality control, and fast service responsiveness.The upstream backbone combines biocompatible polymers, miniaturized sensing/packaging, and sterile single-use manufacturing. Catheters and tubing rely on medical-grade silicone and polyurethane for flexibility and fatigue resistance, with structural and surface-treatment choices aimed at reducing kinking, leakage, and contamination risks. The sensing chain depends on MEMS/strain-based (or related) technologies, signal integrity, connector reliability, and stable microelectronic packaging. Single-use sets—connectors, valves, filtration/collection components, sterile packaging, and validated sterilization—often determine infection-control performance and supply consistency. Competitive focus is extending from console performance to consumable-system quality loops and supply resilience.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Intracranial Pressure Monitor market?

What factors are driving Intracranial Pressure Monitor market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Intracranial Pressure Monitor market opportunities vary by end market size?

How does Intracranial Pressure Monitor break out by Type, by Application?

This report presents a comprehensive overview of the global Intracranial Pressure Monitor market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Invasive
  • Non-invasive

Segment by Placement

  • Intraventricular
  • Intraparenchymal Probe
  • Subdural
  • Other

Segment by Disease Type

  • Traumatic Brain Injury
  • Intracerebral Hemorrhage
  • Meningitis
  • Subarachnoid Hemorrhage
  • Other

Segment by Application

  • Hospital
  • Clinic
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Intracranial Pressure Monitor market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Clinic, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Intracranial Pressure Monitor Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$595
2025
Forecast
$877.1
2032
CAGR
5.7%
2025–2032
Regions
5
global
Key companies
Integra LifeSciencesMedtronicJohnson & JohnsonSophysaRaumedicSpiegelbergHaiWeiKangHeadSense Medical
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
InvasiveNon-invasive
By Application
HospitalClinicOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Invasive
  • 3.1.3 Non-invasive
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Clinic
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Integra LifeSciences
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Medtronic
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Johnson & Johnson
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Sophysa
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Raumedic
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Spiegelberg
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 HaiWeiKang
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 HeadSense Medical
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Vittamed
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Comen
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 PrimaNova
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 TALEND MEDICAL
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Intracranial Pressure Monitor market?
The global Intracranial Pressure Monitor market is estimated at US$ 595 million in 2025 (base year) and is projected to reach US$ 883 million by 2032.
What is the forecast CAGR for the Intracranial Pressure Monitor market?
The market is expected to grow at a CAGR of 5.7% from 2026 to 2032, expanding from US$ 595 million in 2025 to US$ 883 million in 2032, roughly 1.5 times its base-year value.
What is Intracranial Pressure Monitor?
An intracranial pressure (ICP) monitor is a medical device system designed for short-term monitoring and recording of intracranial pressures and pressure trends. It typically includes a pressure sensor/transducer, a bedside monitor with display and alarms, interconnecting hardware, and related single-use components.
How is the Intracranial Pressure Monitor market segmented by type?
By type, the market is segmented into Invasive and Non-invasive.
What are the key applications of Intracranial Pressure Monitor?
Key applications covered include Hospital, Clinic and Other.
Which companies are profiled in the Intracranial Pressure Monitor market report?
Key players profiled include Integra LifeSciences, Medtronic, Johnson & Johnson, Sophysa, Raumedic, Spiegelberg, HaiWeiKang and HeadSense Medical, among 12 companies covered in total.
What geographies does the Intracranial Pressure Monitor market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Intracranial Pressure Monitor?
Across severe brain injury, aneurysmal subarachnoid hemorrhage, hemorrhagic/ischemic edema, hydrocephalus, and post-operative surveillance, demand is increasingly driven by continuous trends and waveform fidelity rather than occasional spot checks.
What are the main risks and barriers in the Intracranial Pressure Monitor market?
Invasive monitoring carries risks such as infection, bleeding, obstruction, calibration constraints, and signal drift, meaning device value depends not only on measurement accuracy but also on insertion workflows, sterile consumable systems, nursing adherence, and practical troubleshooting.
Who should buy the Intracranial Pressure Monitor market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Clinic and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Intracranial Pressure Monitor market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.